We have observed
3 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
December 18, 2012).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
INTRACELLULAR PHENOTYPIC SCREENING
MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA
ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF